prof. Monika Arenberberová, MD, PhD ****************************************************************************************** * ******************************************************************************************
Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Univer Kralovske Vinohrady https://www.lf3.cuni.cz/3LF-998.html [ URL "https://www.lf3.cuni.cz/3LF-998.html"] Topic title Pathogenesis and prevention of acne scars Risk factors of melanoma in adolescent and young adult Epidemiology of hidradenitis suppurativa in the pediatric population *========================================================================================= * Description of scientific activity *========================================================================================= Monika Arenbergerová is an Associate Professor in the Department of Dermatovenereology at of Medicine, Charles University, Prague. Prof. Arenbergerová completed her medical degree at Charles University, Prague. Following research fellowships and physician training at the Free University of Berlin, she obtained Department of Biochemistry and Pathobiochemistry, Charles University. Since 2002, she has at the Department of Dermatology, Královské Vinohrady University Hospital and a medical te Third Faculty of Medicine, Charles University, at which she was appointed Vice Dean in 201 Dr Arenbergerová has broad interests in dermatology and has authored 58 publications in pe journals. Her scientific interests include: Epidemiology of melanoma, immunotherapy of ski pathophysiology of acne vulgaris and hidradenitis suppurativa. At the same time she is inv dermatosurgery and investigates the frequent complications of the surgical interventions i aesthetic dermatology. *========================================================================================= * Selected publications *========================================================================================= Arenbergerova M et al. Position statement of the EADV Melanoma Task Force on recommendatio for the management of cutaneous melanoma patients during COVID-19. [ URL "https:// pubmed.ncbi.nlm.nih.gov/33780557/"] .J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e427-e42 Arenbergerova M et al. Successful treatment of recalcitrant gluteal hidradenitis suppurati brodalumab after anti-TNF failure. [ URL "https://pubmed.ncbi.nlm.nih.gov/32012238/"] Int Jun;59(6):733-735 Dahmen RA, Gkalpakiotis S, Mardesicova L, Arenberger P, Arenbergerova M: Deroofing followe sinus tract excision: a modified surgical approach for hidradenitis suppurativa. [ URL "ht pubmed.ncbi.nlm.nih.gov/31219670/"] J Dtsch Dermatol Ges. 2019 Jul;17(7):698-702. *========================================================================================= * Selected or ongoing grants/clinical studies *========================================================================================= A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurati IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melan Randomized, double-blind, placebo-controlled, Phase IIb/Phase III study to evaluate the ef of spesolimab in patients with moderate to severe hidradenitis suppurativa. *========================================================================================= * PhD Students *========================================================================================= Number of PhD students currently studying: 7 Number of defended students with year of defence: 2 PhD. (2020, 2022)